Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A 107 Gene Nanostring Assay Effectively Translates the Cancer Genome Atlas, and Tumour Microenvironment Gastric Cancer Molecular Classification to a Patient-Derived Organoid Model.

Genes, chromosomes & cancer·2025
Same author

A Hybrid Effectiveness-Implementation Study of the Managing Cancer and Living Meaningfully Psychosocial Intervention Across Established Psychosocial Oncology and Palliative Care Programs in Alberta's Calgary and South Zone.

Psycho-oncology·2025
Same author

[Relationship between depression and sexual drug use in men who have sex with men in Chengdu].

Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi·2025
Same author

Responding to the Growing Need for Medical Experts in Testamentary and Estate Related Capacities: A Course for Physicians.

The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry·2024
Same author

New insight in the immune mechanisms in hyperuricemia after renal transplantation: a narrative review.

European review for medical and pharmacological sciences·2022
Same author

Canadian Surgery Forum.

Canadian journal of surgery. Journal canadien de chirurgie·2022

Related Experiment Video

Updated: Jul 20, 2026

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

Hepatitis C virus replication in mice with chimeric human livers.

D F Mercer1, D E Schiller, J F Elliott

  • 1Surgical-Medical Research Institute, Department of Surgery, University of Alberta, Edmonton, Alberta, Canada.

Nature Medicine
|August 2, 2001
PubMed
Summary

Researchers developed a new mouse model for studying hepatitis C virus (HCV) infection. This chimeric mouse model allows for prolonged HCV infections, aiding antiviral therapy development.

More Related Videos

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
10:56

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis
10:12

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis

Published on: September 11, 2019

Related Experiment Videos

Last Updated: Jul 20, 2026

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
10:56

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis
10:12

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis

Published on: September 11, 2019

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Background:

  • The absence of a suitable small animal model has hindered the development of effective antiviral therapies for hepatitis C virus (HCV).
  • Previous models have been insufficient for studying the complex replication cycle and pathogenesis of HCV in vivo.

Purpose of the Study:

  • To create a small animal model that supports robust human hepatitis C virus (HCV) infection and replication.
  • To facilitate the study of HCV pathogenesis and the evaluation of novel antiviral treatments.

Main Methods:

  • Generation of chimeric mice by transplanting normal human hepatocytes into SCID mice with the Alb-uPA transgene.
  • Inoculation of chimeric mice with human serum infected with hepatitis C virus (HCV).
  • Monitoring of viral load, replication (negative-strand RNA), protein expression, and serial passaging.

Main Results:

  • Homozygosity for the Alb-uPA transgene significantly enhanced human hepatocyte engraftment.
  • Chimeric mice developed prolonged HCV infections with high viral titers, showing up to a 1950-fold increase in viral load.
  • HCV replication was confirmed by detecting negative-strand viral RNA, and viral proteins were localized to human hepatocytes.
  • Infectious viral particles were synthesized and released, enabling serial passage through three generations of mice.

Conclusions:

  • The developed chimeric mouse model is the first murine system capable of supporting in vivo human hepatitis C virus (HCV) infection.
  • This model provides a valuable platform for investigating HCV pathogenesis and for preclinical testing of antiviral drugs.